Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Repulsed By Shire's Magnetic Promotion Of Vyvanse

This article was originally published in The Pink Sheet Daily

Executive Summary

DDMAC warning letter objects to a promotional magnet that obscures risk information; Bad Ad program draws attention to the tchotchke, which Shire stopped distributing in 2008.
Advertisement

Related Content

"Bad Ad" Program Set To Expand After Opening Spigot Of Complaints In Year One
"Bad Ad" Program Set To Expand After Opening Spigot Of Complaints In Year One
"Bad Ad" On YouTube Snags Warner Chilcott
Short Attention Span? Shire Cited Again For Out-Of-Bounds ADHD Promotion
FDA Deputizes Doctors In Hunt For "Bad Ads"
FDA Deputizes Doctors In Hunt For "Bad Ads"

Topics

Advertisement
UsernamePublicRestriction

Register

PS072247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel